<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorder</z:e> characterized by manifestations in the cardiovascular, skeletal, ocular, and other organ systems </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> type1 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS1</z:e>) is caused by mutations in the gene encoding fibrillin (FBN1) </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, the transforming growth factor-beta receptor-2 gene, TGFBR2, has been shown to be associated with a second type of this disorder with typically mild or absent ocular involvement (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> type 2; MFS2) </plain></SENT>
<SENT sid="3" pm="."><plain>Several point mutations were found in the highly conserved serine/threonine kinase domain of TGFBR2 </plain></SENT>
<SENT sid="4" pm="."><plain>Mutations in both TGFBR1 and TGFBR2 are associated with Loeys-Dietz <z:hpo ids='HP_0004942'>aortic aneurysm</z:hpo> syndrome (LDS) </plain></SENT>
<SENT sid="5" pm="."><plain>We searched for TGFBR1 and TGFBR2 mutations in 41 unrelated patients fulfilling the diagnostic criteria of Ghent nosology or with the tentative diagnosis of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, in whom mutations in the FBN1 coding region were not identified </plain></SENT>
<SENT sid="6" pm="."><plain>In TGFBR1, two mutations and two polymorphisms were detected </plain></SENT>
<SENT sid="7" pm="."><plain>In TGFBR2, five mutations and six polymorphisms were identified </plain></SENT>
<SENT sid="8" pm="."><plain>Reexamination of patients with a TGFBR1 or TGFBR2 mutation revealed extensive clinical overlap between patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS1</z:e>, MFS2, and LDS </plain></SENT>
</text></document>